ArticleBMC cardiovascular disorders2026
Epicardial fat is associated with prevalent heart failure and adverse cardiac remodeling in atrial fibrillation.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAtrial fibrillation (AF) frequently coexists with cardiometabolic conditions such as diabetes and heart failure (HF), which increase morbidity and mortality. While body mass index (BMI) is widely used for risk stratification, regional adiposity measures including epicardial adipose tissue (EAT) and EAT indexed to body surface area (iEAT) may better reflect local cardiac fat burden and its association with conditions of adverse cardiac remodeling.
methodsWe identified 348 participants from an AF registry with EAT area quantified from a pre-ablation CT scan. Echocardiographic parameters and clinical covariates were collected from the electronic medical record. Adiposity measures were analyzed in tertiles. Multivariable logistic regression models adjusted for age, sex, and race assessed associations between adiposity and outcomes. ROC curves were used to compare predictive performance. Multivariable linear regression analysis assessed echocardiographic parameters, including left ventricular (LV) ejection fraction, LV dimensions, LV mass, left atrial anteroposterior diameter, and pulmonary artery systolic pressure.
resultsAmong 348 participants, higher BMI, EAT and iEAT were each associated with older age and increased prevalence of cardiometabolic comorbidity. In multivariable models, the highest tertiles of EAT and iEAT were each independently associated with heart failure [EAT OR 4.83 (95% CI 1.82-12.84); iEAT OR 4.40 (95% CI 1.70-11.43)]. ROC analysis showed that iEAT best discriminated heart failure (AUC = 0.74), while BMI best discriminated diabetes (AUC = 0.69). In adjusted models, all three adiposity metrics were significantly associated with higher LV mass; EAT and iEAT were additionally linked to higher pulmonary artery systolic pressure.
conclusionIn patients with atrial fibrillation, epicardial adiposity measures were more strongly associated with prevalent heart failure than BMI, possibly due to its association with adverse cardiac remodeling. In contrast, BMI remains a stronger predictor of diabetes. Incorporating epicardial fat may enhance risk stratification for heart failure in patients with atrial fibrillation beyond BMI alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.